Cargando…
Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Spr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819359/ https://www.ncbi.nlm.nih.gov/pubmed/27051195 http://dx.doi.org/10.14202/vetworld.2016.118-122 |
_version_ | 1782425184253247488 |
---|---|
author | Kavitha, K. Reddy, A. Gopala Reddy, K. Kondal Kumar, C. S. V. Satish Boobalan, G. Jayakanth, K. |
author_facet | Kavitha, K. Reddy, A. Gopala Reddy, K. Kondal Kumar, C. S. V. Satish Boobalan, G. Jayakanth, K. |
author_sort | Kavitha, K. |
collection | PubMed |
description | AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley rats. The rats were divided randomly into six groups of six rats in each. Group 1 was maintained as a normal control. Group 2 was maintained as diabetic control; Group 3 was treated with insulin; Group 4 with insulin + synbiotic; Group 5 with insulin + pioglitazone; and Group 6 with insulin + synbiotic + pioglitazone. All the animals were treated for 60 days. RESULTS: Body weights, and concentration of reduced glutathione (GSH), and high-density lipoproteins cholesterol were significantly (p<0.05) reduced, whereas the concentration of blood glucose, total cholesterol, triglycerides, protein carbonyls and thiobarbituric acid reacting substances, and the activity of GSH peroxidase were significantly (p<0.05) elevated in Group 2 at the end of 8(th) week as compared to Group 1. The treatment Groups 3, 4, 5 and 6 revealed improvement in all the parameters, and the highest improvement was observed in combination Group 6. CONCLUSION: From this study, it is concluded that combination of insulin, pioglitazone and synbiotic is useful in treating diabetes. |
format | Online Article Text |
id | pubmed-4819359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Veterinary World |
record_format | MEDLINE/PubMed |
spelling | pubmed-48193592016-04-05 Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats Kavitha, K. Reddy, A. Gopala Reddy, K. Kondal Kumar, C. S. V. Satish Boobalan, G. Jayakanth, K. Vet World Research Article AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley rats. The rats were divided randomly into six groups of six rats in each. Group 1 was maintained as a normal control. Group 2 was maintained as diabetic control; Group 3 was treated with insulin; Group 4 with insulin + synbiotic; Group 5 with insulin + pioglitazone; and Group 6 with insulin + synbiotic + pioglitazone. All the animals were treated for 60 days. RESULTS: Body weights, and concentration of reduced glutathione (GSH), and high-density lipoproteins cholesterol were significantly (p<0.05) reduced, whereas the concentration of blood glucose, total cholesterol, triglycerides, protein carbonyls and thiobarbituric acid reacting substances, and the activity of GSH peroxidase were significantly (p<0.05) elevated in Group 2 at the end of 8(th) week as compared to Group 1. The treatment Groups 3, 4, 5 and 6 revealed improvement in all the parameters, and the highest improvement was observed in combination Group 6. CONCLUSION: From this study, it is concluded that combination of insulin, pioglitazone and synbiotic is useful in treating diabetes. Veterinary World 2016-02 2016-02-03 /pmc/articles/PMC4819359/ /pubmed/27051195 http://dx.doi.org/10.14202/vetworld.2016.118-122 Text en Copyright: © Kavitha, et al. http://creativecommons.org/licenses/by/4.0 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Kavitha, K. Reddy, A. Gopala Reddy, K. Kondal Kumar, C. S. V. Satish Boobalan, G. Jayakanth, K. Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title | Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title_full | Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title_fullStr | Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title_full_unstemmed | Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title_short | Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
title_sort | hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819359/ https://www.ncbi.nlm.nih.gov/pubmed/27051195 http://dx.doi.org/10.14202/vetworld.2016.118-122 |
work_keys_str_mv | AT kavithak hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats AT reddyagopala hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats AT reddykkondal hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats AT kumarcsvsatish hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats AT boobalang hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats AT jayakanthk hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats |